Essex LLC’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Hold
2,650
0.04% 160
2026
Q1
$226K Buy
+2,650
New +$236K 0.04% 161
2025
Q2
Sell
-2,650
Closed -$242K 180
2025
Q1
$248K Buy
+2,650
New +$237K 0.05% 150
2024
Q3
Sell
-2,650
Closed -$270K 171
2024
Q2
$257K Hold
2,650
0.06% 143
2024
Q1
$239K Hold
2,650
0.06% 136
2023
Q4
$211K Buy
+2,650
New +$199K 0.05% 146
2023
Q3
Sell
-2,650
Closed -$204K 161
2023
Q2
$204K Sell
2,650
-350
-12% -$27.1K 0.06% 146
2023
Q1
$236K Hold
3,000
0.07% 138
2022
Q4
$236K Hold
3,000
0.07% 138
2022
Q3
$211K Hold
3,000
0.07% 140
2022
Q2
$240K Hold
3,000
0.07% 138
2022
Q1
$227K Hold
3,000
0.06% 153
2021
Q4
$256K Hold
3,000
0.07% 153
2021
Q3
$227K Buy
+3,000
New +$238K 0.06% 156

Other funds holding CL

Essex LLC's CL Position: Q2 2026 in Review

Essex LLC held its Colgate-Palmolive (CL) position steady in Q2 2026 at 2,650 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #160.

Essex LLC first reported a position in CL in Q3 2021 and has held it in 14 quarters since. The position peaked at $257K in Q2 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Essex LLC held 2,650 shares of Colgate-Palmolive worth $243K as of Q2 2026.
  • Essex LLC left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.04% of Essex LLC's portfolio in Q2 2026, its #160 holding.
  • Essex LLC first reported a position in Colgate-Palmolive in Q3 2021 and has held it in 14 quarters since.
  • Essex LLC's Colgate-Palmolive position peaked at $257K in Q2 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.